Skip to main content
. 2017 Jun 27;10:3187–3192. doi: 10.2147/OTT.S139718

Table 2.

Details of the treatment process

Treatment Time Curative effect
Albumin paclitaxel + cisplatin, 2 cycles; albumin paclitaxel, 3 cycles October 2014 to February 2015 SD
Anlotinib (clinical trial) September 2015 to June 2016 SD
Gemcitabine + Nedaplatin June 2016 to August 2016 PD
Docetaxel + bevacizumab, 4 cycles; bevacizumab, 2 cycles August 2016 to November 2016 SD
Rechallenge with crizotinib November 2016 to December 2016 PD

Abbreviations: SD, stable disease; PD, progressive disease.